Table 1.

Clinical characteristics.

Age (mean ± SD, years)	71 ± 12
tPA (n, %)	62 (69)
Occlusion location:
T-ICA (n, %)	23 (29)
M1 (n, %)	54 (64)
M2 (n, %)	24 (28)
RAPID data analysis (mean ± SD)
CBF >30% vol	26 ± 36 ml
Tmax >6 s	100 ± 64 ml
Mismatch ratio	13.4 ± 14.2
Mismatch volume	74 ± 50 ml
NIHSS Score (mean± SD)
Before therapy	15 ± 7
24h after therapy	9 ± 8
Difference	−5 ± 8
Recanalisation time from onset	217 ± 99
mRS score 90 days (n = 62)
0 (n, %)	8 (13)
1 (n, %)	14 (23)
2 (n, %)	9 (15)
3 (n, %)	10 (16)
4 (n, %)	4 (6)
5 (n, %)	1 (2)
6 (n, %)	14 (23)

SD, Standard Deviation; tPA, tissue Plasminogen Activator; ICA, Internal Carotid Artery; M1, M1 division of the Middle Cerebral Artery; M2, M2 division of the Middle Cerebral Artery; CBF, Cerebral Blood Flow; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale.